- Home
- KYMR vs NPO Comparison
KYMR vs NPO Comparison
Compare KYMR & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- NPO
- Stock Information
- Founded
- KYMR 2015
- NPO 2002
- Country
- KYMR United States
- NPO United States
- Employees
- KYMR N/A
- NPO 3500
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- NPO Metal Fabrications
- Sector
- KYMR Health Care
- NPO Industrials
- Exchange
- KYMR Nasdaq
- NPO Nasdaq
- Market Cap
- KYMR 4.3B
- NPO 4.9B
- IPO Year
- KYMR 2020
- NPO N/A
- Fundamental
- Price
- KYMR $59.94
- NPO $227.48
- Analyst Decision
- KYMR Strong Buy
- NPO Buy
- Analyst Count
- KYMR 19
- NPO 3
- Target Price
- KYMR $66.84
- NPO $243.33
- AVG Volume (30 Days)
- KYMR 631.1K
- NPO 202.4K
- Earning Date
- KYMR 11-04-2025
- NPO 11-04-2025
- Dividend Yield
- KYMR N/A
- NPO 0.56%
- EPS Growth
- KYMR N/A
- NPO 58.40
- EPS
- KYMR N/A
- NPO 4.06
- Revenue
- KYMR $43,735,000.00
- NPO $1,106,300,000.00
- Revenue This Year
- KYMR $60.88
- NPO $7.28
- Revenue Next Year
- KYMR N/A
- NPO $5.60
- P/E Ratio
- KYMR N/A
- NPO $54.12
- Revenue Growth
- KYMR N/A
- NPO 6.44
- 52 Week Low
- KYMR $19.45
- NPO $133.50
- 52 Week High
- KYMR $63.96
- NPO $248.88
- Technical
- Relative Strength Index (RSI)
- KYMR 55.80
- NPO 50.40
- Support Level
- KYMR $55.66
- NPO $217.62
- Resistance Level
- KYMR $63.36
- NPO $248.88
- Average True Range (ATR)
- KYMR 3.07
- NPO 9.16
- MACD
- KYMR -0.37
- NPO -0.71
- Stochastic Oscillator
- KYMR 57.78
- NPO 31.55
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.